Tectonic Therapeutic (TECX) Interest Coverage Ratio (2017 - 2026)
Tectonic Therapeutic (TECX) reported Interest Coverage Ratio of 3412.62 for Q1 2026, down 273.01% year-over-year from 1972.56 in Q1 2025, and down 90.33% quarter-over-quarter from 1793.0 in Q4 2025.
Tectonic Therapeutic (TECX) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Interest Coverage Ratio data on file, last reported at 3412.62 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 3412.62, down 273.01% year-over-year; the trailing twelve-month figure through Mar 2026 was 1824.29 (down 173.59% YoY), and the FY2025 annual result was 1333.9, down 146.02% from the prior year.
- Interest Coverage Ratio declined to 3412.62 in Q1 2026 per TECX's latest filing, from 1793.0 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 265.77 in Q2 2023 and troughed at 3412.62 in Q1 2026.
- A 5-year average of 978.58 and a median of 653.73 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2026: Interest Coverage Ratio surged 39.21% in 2022, then sank 273.01% in 2026.
- A 5-year view of Interest Coverage Ratio shows it stood at 653.73 in 2022, then soared by 57.83% to 275.71 in 2023, then slumped by 130.66% to 635.95 in 2024, then sank by 181.94% to 1793.0 in 2025, then slumped by 90.33% to 3412.62 in 2026.
- Business Quant data shows TECX's Interest Coverage Ratio at 3412.62 in Q1 2026, 1793.0 in Q4 2025, and 1563.57 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -3,412.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,412.63 |
| Dec 31, 2025 | -1,793.00 |
| Sep 30, 2025 | -1,563.57 |
| Jun 30, 2025 | -1,313.65 |
| Mar 31, 2025 | -914.90 |
| Dec 31, 2024 | -635.95 |
| Sep 30, 2024 | -785.48 |
| Jun 30, 2024 | -407.89 |
| Mar 31, 2024 | -418.32 |
| Dec 31, 2023 | -275.71 |
| Sep 30, 2023 | -280.94 |
| Jun 30, 2023 | -265.78 |
| Mar 31, 2022 | -653.73 |
| Jun 30, 2021 | -1,494.05 |
| Mar 31, 2021 | -1,075.36 |
| Dec 31, 2020 | -350.80 |
| Sep 30, 2020 | -496.19 |
| Jun 30, 2020 | -874.45 |
| Mar 31, 2020 | -1,661.81 |
| Dec 31, 2019 | -1,378.41 |